IL135087A - Process for purifying peptides, polypeptides and biologically active non-peptidyl compounds - Google Patents

Process for purifying peptides, polypeptides and biologically active non-peptidyl compounds

Info

Publication number
IL135087A
IL135087A IL13508798A IL13508798A IL135087A IL 135087 A IL135087 A IL 135087A IL 13508798 A IL13508798 A IL 13508798A IL 13508798 A IL13508798 A IL 13508798A IL 135087 A IL135087 A IL 135087A
Authority
IL
Israel
Prior art keywords
biologically active
active non
polypeptides
peptidyl compounds
purifying peptides
Prior art date
Application number
IL13508798A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL135087A publication Critical patent/IL135087A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL13508798A 1997-10-24 1998-10-08 Process for purifying peptides, polypeptides and biologically active non-peptidyl compounds IL135087A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95776097A 1997-10-24 1997-10-24

Publications (1)

Publication Number Publication Date
IL135087A true IL135087A (en) 2005-05-17

Family

ID=25500093

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13508798A IL135087A (en) 1997-10-24 1998-10-08 Process for purifying peptides, polypeptides and biologically active non-peptidyl compounds

Country Status (12)

Country Link
EP (1) EP1025126B1 (de)
JP (1) JP4239131B2 (de)
AT (1) ATE237636T1 (de)
AU (1) AU740665B2 (de)
CA (1) CA2306447C (de)
DE (1) DE69813599T2 (de)
DK (1) DK1025126T3 (de)
ES (1) ES2195409T3 (de)
IL (1) IL135087A (de)
PT (1) PT1025126E (de)
WO (1) WO1999021889A1 (de)
ZA (1) ZA989424B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003002136A2 (en) 2001-06-28 2003-01-09 Novo Nordisk A/S Stable formulation of modified glp-1
KR101308912B1 (ko) 2003-06-03 2013-09-23 노보 노르디스크 에이/에스 안정화된 약학적 펩티드 조성물
EP1633391B1 (de) 2003-06-03 2011-10-19 Novo Nordisk A/S Stabilisierte pharmazeutische peptid zusammensetzungen
EP1687019B1 (de) 2003-11-20 2017-11-22 Novo Nordisk A/S Für die herstellung und verwendung in injektionsvorrichtungen optimale propylenglykol enhaltende peptidformulierungen
PL1789434T3 (pl) * 2004-08-31 2014-07-31 Novo Nordisk As Zastosowanie tris(hydroksymetylo)aminometanu do stabilizacji peptydów, polipeptydów i białek
EP2494983B1 (de) 2004-11-12 2019-04-24 Novo Nordisk A/S Stabile formulierung von glp-1
US8921518B2 (en) 2005-12-23 2014-12-30 Novo Nordisk A/S Purification of proteins using preparative reverse phase chromatography (RPC)
JP6088435B2 (ja) 2010-12-15 2017-03-01 バクスアルタ ゲーエムベーハー 導電率グラディエントを用いる溶出液収集
CA3082033A1 (en) 2017-08-24 2019-02-28 Novo Nordisk A\S Glp-1 compositions and uses thereof
US11318191B2 (en) 2020-02-18 2022-05-03 Novo Nordisk A/S GLP-1 compositions and uses thereof
CN116754678B (zh) * 2023-06-19 2025-09-16 杭州度安医学检验实验室有限公司 一种血液中胰岛素样生长因子检测样本的处理及检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
US5446024A (en) * 1993-12-17 1995-08-29 Genentech, Inc. Purification of insulin-like growth factor

Also Published As

Publication number Publication date
JP2001521044A (ja) 2001-11-06
PT1025126E (pt) 2003-09-30
EP1025126A1 (de) 2000-08-09
DE69813599T2 (de) 2004-04-08
AU1072599A (en) 1999-05-17
DK1025126T3 (da) 2003-08-04
JP4239131B2 (ja) 2009-03-18
ATE237636T1 (de) 2003-05-15
AU740665B2 (en) 2001-11-08
ES2195409T3 (es) 2003-12-01
CA2306447C (en) 2009-04-07
EP1025126B1 (de) 2003-04-16
DE69813599D1 (de) 2003-05-22
WO1999021889A1 (en) 1999-05-06
ZA989424B (en) 2000-04-17
HK1031387A1 (en) 2001-06-15
CA2306447A1 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
IL135087A (en) Process for purifying peptides, polypeptides and biologically active non-peptidyl compounds
IL110589A0 (en) Growth/differentiation factor of the TGF- beta family
IE852913L (en) Purifying proteins
CA2277832A1 (en) Cyclic peptides that bind to urokinase-type plasminogen activator receptor
AU1843395A (en) Antibody purification
ZA948551B (en) Chimeric proteins comprising borrelia polypeptides; uses therefor
Lundanes et al. Reversed-phase chromatography of peptides
ATE338059T1 (de) Reinigung von echinocandin cyclopeptiden
EP0644769A4 (de) Biologisch aktive peptide mit n-terminalen substitutionen.
AU1392692A (en) Injection-type chemical composition for stabilization and reinforcement process using the same
ZA942206B (en) Biologically active polypeptide fusion dimers
AU7017494A (en) Purified mammalian flt3 ligands and agonists and antagonists thereof
ZA934780B (en) A process for recovering a recombinant protein in biologically active from a solution containing inactive protein
IE902388L (en) Vasoactive intestinal peptide analogs.
EP0783521B8 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
GB9511909D0 (en) Vaccine
ZA948410B (en) Metal-binding cysteine free peptides.
JPS51125790A (en) Carrier for fixing of biologically active substances
Basak et al. Affinity purification of proteinases by a combination of immobilized peptidyl aldehyde and semicarbazone
DE69415664D1 (de) Methode zur trennung von glykosylierten und unglykosylierten proteinen
HU9200507D0 (en) Novel method for the indentification of biologically active peptides from peptide mixtures in attacment-testing experiments
DE69420044D1 (de) Blutregulierende peptide
Angelova et al. Effect of mobile phase composition on selectivity in preparative hydrophobic interaction chromatographic purification of glucagon
Wang Studies of distorted amides as models for activated peptide NC (O) units
EP1032586A4 (de) Hypusin enthaltende peptide

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired